Digital health company Endotronix has raised $32 million in its Series C round funding that will help finance development on its cloud-based patient management system and artery sensors.

Galen Wagner, MD, a cardiologist and founding member of the Duke Clinical Research Institute, died July 13 after a long illness. He was 76.

Adults who developed heart failure after their first MI had an increased risk of cancer compared with those who did not have heart failure, according to a prospective cohort study of Olmsted County, Minnesota, residents.

The FDA approved a device from Amgen that provides a monthly, single dose of evolocumab (Repatha) to lower low-density lipoprotein (LDL) cholesterol.

Alere voluntarily recalled its INRatio and INRatio 2 prothrombin time/international normalized ratio (PT/INR) monitoring system, according to a July 12 announcement.

Yoshiaki Fujimori, a former Lixil Group Corporation CEO and General Electric executive, was elected to Boston Scientific’s board of directors on July 13.

By relying on so many drugs to treat their disease, patients with heart failure are putting themselves at risk of medical issues, according to an AHA scientific statement.

Patients with rheumatoid arthritis who received immunotherapy had a decrease in cardiovascular risk, according to a recent study.